A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. MRC Advanced Bladder Cancer Working Party.

Transitional cell carcinomas may arise at any site within the urinary tract and are a source of considerable morbidity and mortality. In particular, patients with metastatic disease have a poor prognosis, with less than 5% alive at 5 years. A multicentre randomized trial comparing methotrexate and v...

Descripción completa

Detalles Bibliográficos
Autores principales: Mead, G. M., Russell, M., Clark, P., Harland, S. J., Harper, P. G., Cowan, R., Roberts, J. T., Uscinska, B. M., Griffiths, G. O., Parmar, M. K.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group|1 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063167/
https://www.ncbi.nlm.nih.gov/pubmed/9792152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063167/
https://www.ncbi.nlm.nih.gov/pubmed/9792152

Ejemplares similares